Groundbreaking new vaccine shrinks cysts of America’s deadliest cancer
An experimental vaccine may offer a way to intercept pancreatic cancer before it becomes invasive, potentially preventing the disease in people born with a high genetic risk. The new vaccine targets a KRAS mutation found in more than 90 percent of pancreatic cancers, or roughly 60,000 of the more than 67,000 Americans diagnosed with the disease annually. …
Groundbreaking new vaccine shrinks cysts of America’s deadliest cancer Read More »